Intas Pharmaceuticals
Hemant Mali currently serves as an Executive at Intas Pharmaceuticals, a position held since January 2025. Previously, Hemant contributed as a Senior Officer at Troikaa Pharmaceuticals Ltd. from January 2023 to January 2025, and held a role at Sun Pharma from December 2021 to January 2023. Earlier experience includes serving as an Officer at Amneal Pharmaceuticals from December 2019 to February 2022.
This person is not in the org chart
This person is not in any teams
Intas Pharmaceuticals
2 followers
Intas Pharmaceuticals Ltd. is an India-based pharmaceutical formulation development, manufacturing and marketing company. The Company offers products for the treatment of cardiovascular system (CVS), diabetology, gynecology, infertility, respiratory care, gastroenterology, pain management, as well as other therapeutic segments. Its pharma products include ACUTROL-400, ADAPEN GEL, ADIFLOX, ALZIL 10, ALZIL M 10 and AMITONE 10. The Company's biologics products include Albucel 20%, Epofit, Erykine, Factocel VIII, MabTas, Neukine and Neupeg. It range of products for animal health includes AC-Vet, AC-Vet Forte, AC-Vet Max, Alzonic, Anistamin, Benezepril, Bufzone, Calshakti Platina and Carprofen Inj. The Company offers approximately 10 biologic products and is engaged in research and development in chronic disease areas, such as oncology (cancer), rheumatology, auto-immune, nephrology, ophthalmology and plasma derived product based therapies.